Carl Zeiss Meditec Investor Presentation 2021

Carl Zeiss Meditec Group presents financial performance and strategic positioning as a leader in ophthalmology and microsurgery markets. The presentation covers revenue development, market leadership positions, and operational metrics for fiscal year 2019/20, with total revenue of €1,459 million and EBIT margin of 18.1%.